Clinical Trials Browser

Recruiting × Stomach Neoplasms × anlotinib × Clear all

NCT04278222 2024-07-10

Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms